It has long been puzzling scientists in the field of cell death that cancer cells constitutively expressed TRAIL-R1 and TRAIL-R2 and could therefore be targeted by TRAIL-based apoptotic therapy. The gene discussed is TNFRSF10B; the disease is cancer.